Pharmacy |
| ||
|
Ol Vamlo Generic Olmesartan |
|
| ||
Home » Prescription Drugs 12 » Ol Vamlo Generic Olmesartan Ol-Vamlo is combination medications to treat high blood pressure and chest pain. Olmesartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain chemicals that tighten the blood vessels so blood flows more smoothly.Amlodipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood to the heart. If taken regularly amlodipine controls chest pain but it does not stop chest pain once it starts. Your doctor may prescribe a different medication to take when you have chest pain. Buy Ol Vamlo Generic Olmesartan and other Prescription Drugs 12 products online at Medstore. Buy Online at Medstore - Click Here!
About Ol Vamlo Generic Olmesartan: Product Type: Prescription Drugs 12 Ol-Vamlo (Generic Olmesartan/Amlodipine) Ol-Vamlo (Generic Olmesartan/Amlodipine) Generic Olmesartan/Amlodipine 20/5mg Generic Olmesartan/Amlodipine Ol-Vamlo
View more Prescription Drugs 12 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
